SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EARNINGS FLASH L impact

Apimeds Pharmaceuticals US, Inc. (APUS) Reports $2.89M Revenue and $2.0M Operating Income

Third-quarter revenue was $2.89M and operating income was $2.0M. For the nine months ended September 30, 2026, revenue was $3.2M and net loss was $21.6M; the company cited substantial doubt about its ability to continue as a going concern.Material DetailsContext by AI AnalystThis is an early-stage…

APUS

Related stories